Short interest in Contineum Therapeutics Inc (NASDAQ:CTNM) decreased during the last reporting period, falling from 1.05M to 1.04M. This put -% of the company's publicly available shares short.

Short interest for Contineum Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Contineum Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 74.44K shares traded per day, it would take 13.94 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.